Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry.

The structural relaxation time is a measure of the molecular mobility involved in enthalpy relaxation, and thus, is a measure of the dynamics of amorphous (glassy) pharmaceutical solids that determines physicochemical properties and reactivity of drugs in amorphous formulations. In this article we describe a novel method for characterization of structural relaxation using isothermal microcalorimetry, which directly measures the rate of heat release during the relaxation processes. The structural relaxation time is then obtained from a fit of the power data to the derivative version of the Kohlrausch-Williams-Watts (KWW) equation. The relaxation times of quenched and lyophilized samples of saccharides were studied using an isothermal microcalorimeter, the Thermal Activity Monitor (TAM). In addition to the KWW derivative function, a derivative equation of the modified stretched exponential function (MSE) was employed to evaluate TAM data. The later (MSE) appeared to have numerical advantages over the KWW equation. The data demonstrate, as expected, that structural relaxation times of amorphous solids depend on a number of variables, including nature of material, temperature, moisture content, thermal history, etc. Isothermal microcalorimetry with the TAM provides a very fast and reliable way to characterize the dynamics of glassy materials, which in many respects is superior to the conventional DSC approach. To the extent stability and structural relaxation dynamics in the glass are correlated, structural relaxation parameters derived by isothermal microcalorimetry may provide data useful for rational development of stable peptide and protein formulations and for the control of their processing.

[1]  M. Pikal,et al.  Stability testing of pharmaceuticals by high-sensitivity isothermal calorimetry at 25°C: cephalosporins in the solid and aqueous solution states☆ , 1989 .

[2]  J. Boerio-goates,et al.  Heat-capacity measurements and thermodynamic functions of crystalline sucrose at temperatures from 5 K to 342 K. Revised values for ΔfGom(sucrose, cr, 298.15 K), ΔfGom(sucrose, aq, 298.15 K), Som(sucrose, aq, 298.15 K); and ΔrGom(298.15 K) for the hydrolysis of aqueous sucrose , 1993 .

[3]  The Modified Stretched-Exponential Model for Characterization of NMR Relaxation in Porous Media , 1996 .

[4]  D. Hansen Instrument selection for calorimetric drug stability studies , 1996 .

[5]  Danièle Giron,et al.  Contribution of thermal methods and related techniques to the rational development of pharmaceuticals—Part 2 , 1998 .

[6]  Michael J. Pikal,et al.  MECHANISMS OF PROTEIN STABILIZATION DURING FREEZE-DRYING AND STORAGE : THERELATIVE IMPORTANCE OF THERMODYNAMIC STABILIZATION AND GLASSY STATE RELAXAT ION DYNAMICS , 1999 .

[7]  P Augustijns,et al.  Stability prediction of amorphous benzodiazepines by calculation of the mean relaxation time constant using the Williams-Watts decay function. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  D. Craig,et al.  The effects of experimental parameters and calibration on MTDSC data. , 1999, International journal of pharmaceutics.

[9]  J. Mitchell,et al.  Pharmaceutical microcalorimetry: applications to long-term stability studies. , 1999, International journal of pharmaceutics.

[10]  Bruno C. Hancock,et al.  Interpretation of relaxation time constants for amorphous pharmaceutical systems. , 2000, Journal of pharmaceutical sciences.

[11]  P. Royall,et al.  Characterization of amorphous ketoconazole using modulated temperature differential scanning calorimetry. , 2001, Journal of pharmaceutical sciences.

[12]  M. Pikal,et al.  The Stability of Insulin in Crystalline and Amorphous Solids: Observation of Greater Stability for the Amorphous Form , 1997, Pharmaceutical Research.

[13]  Bruno C. Hancock,et al.  Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures , 1995, Pharmaceutical Research.

[14]  P. Royall,et al.  An Evaluation of the Use of Modulated Temperature DSC as a Means of Assessing the Relaxation Behaviour of Amorphous Lactose , 2000, Pharmaceutical Research.

[15]  Richard A. Couch,et al.  Solid-State Stability Testing of Drugs by Isothermal Calorimetry , 1992, Pharmaceutical Research.